Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Articles

Characterization of a Unique Cell Line (LAZ 221) from Human Acute Lymphocytic (“Null” Cell) Leukemia

Herbert Lazarus, Elizabeth F. Barell, Awtar Krishan, David M. Livingston, Kathleen Harris, Stuart F. Schlossman and Leonard Chess
Herbert Lazarus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth F. Barell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Awtar Krishan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Livingston
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen Harris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart F. Schlossman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonard Chess
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 1978
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

A unique human cell line designated LAZ 221 has been established from the peripheral blood of a patient with acute lymphocytic leukemia of the “null” cell type. The cell line does not possess the Epstein-Barr virus nuclear antigen and has a karyotype of 45,XX,-9,-12,+t(9q12q). Both the established cell line and the patient's uncultured blast cells share the same phenotypic markers. They both lack T-cell markers. They fail to form sheep erythrocyte rosettes and do not react with T-cell-specific antisera (TH1-, HTL-), nor do they possess B-cell markers. They do not form rosettes with erythrocytes sensitized with complement, and they are surface immunoglobulin negative. However, they do possess an HLA-D-related glycoprotein complex of 23,000 to 30,000 daltons, an la-like antigen. Thus, LAZ 221 shares the phenotype of the patient's uncultured blasts and is a cell line representative of about 75% of all human acute lymphocytic leukemias. In this respect it differs from previously described human hematopoietic cell lines.

Footnotes

  • ↵1 This work was supported in part by Contracts N01 CP 53539 and N01 CB 43964 from the National Cancer Institute, NIH.

  • Received September 23, 1977.
  • Accepted January 30, 1978.
  • ©1978 American Association for Cancer Research.
PreviousNext
Back to top
May 1978
Volume 38, Issue 5
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of a Unique Cell Line (LAZ 221) from Human Acute Lymphocytic (“Null” Cell) Leukemia
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Characterization of a Unique Cell Line (LAZ 221) from Human Acute Lymphocytic (“Null” Cell) Leukemia
Herbert Lazarus, Elizabeth F. Barell, Awtar Krishan, David M. Livingston, Kathleen Harris, Stuart F. Schlossman and Leonard Chess
Cancer Res May 1 1978 (38) (5) 1362-1367;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Characterization of a Unique Cell Line (LAZ 221) from Human Acute Lymphocytic (“Null” Cell) Leukemia
Herbert Lazarus, Elizabeth F. Barell, Awtar Krishan, David M. Livingston, Kathleen Harris, Stuart F. Schlossman and Leonard Chess
Cancer Res May 1 1978 (38) (5) 1362-1367;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Insights from Bcl-2 and Myc: Malignancy Involves Abrogation of Apoptosis as well as Sustained Proliferation
  • Core-Binding Factor: A Central Player in Hematopoiesis and Leukemia
  • Introduction of Stanley J. Korsmeyer
Show more Articles
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement